BlueBlox×Sales-Automation.ai

Lead Sourcing Snapshot

ICP 02 + ICP 04 · 25.10.26

A first, quick and dirty ICP research based on your ICP 02 and 04 documents: how many MedTech manufacturers and decision-makers our lead data aggregators find in the US and Europe, before any filtering.

Raw count

Who we can reach

MedTech manufacturers headquartered in the US and Europe, 11 to 5,000 employees.

49,565
MedTech companies
554,126
employee profiles in them
75,684
leaders (C-level, VP, Director)
30,972
in the exact roles of your ICPs

Raw matches from our lead data aggregators, 25 Oct 2026. Not yet qualified on company or person level. Europe = EU, UK, Switzerland, Norway, Iceland, Liechtenstein.

Next step

From raw count to the right conversations

We narrow the raw matches down company by company, then person by person.

01

Company check

We read each company’s own website: a physical regulated medical product, not pure digital health or a distributor.

Company
02

ICP and footprint

ICP 02 or 04 by maturity, and where they sell today: US only, Europe only, both, or the rest of the world.

Company
03

Situation and trigger

New market, funding round, approval, distributor change: why this company would talk to you now.

Company
04

The right person

The decision-maker who feels the pain most, from the roles in your ICPs, checked on their current profile.

Person
FridayWe pick one first test cell together in our weekly, then run steps 1 to 4 on it.